Parkinson´s Disease Clinical Trial
Verified date | August 2009 |
Source | Universidade Federal de Sao Carlos |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
Background: Studies about the effects of walking training with additional body load in
Parkinson's disease (PD) are lacking. There is evidence that the increase of body load
during treadmill walking improves reflex activity and leg extensor muscle activity, which
are impaired in subjects with PD.
Purpose: The purpose of this study was to assess the effects of treadmill walking training
with additional body load on the ground reaction forces, spatiotemporal, and kinematic
variables of the gait of subjects with moderate PD.
Design: This study was an A1-B-A2 single-case. Setting: The evaluation and the training were
conducted in a movement analysis laboratory, and at the rehabilitation unit of the
University, respectively.
Participants: Nine patients with PD (Hoehn and Yahr 2 through 3) and gait disturbances.
Interventions: Phases A1 and A2 included 6 weeks of gait training on a treadmill with 10%
increase of normal body mass. Phase B included 6 weeks of conventional physical therapy.
Measurements: Measures included the ground reaction forces, spatiotemporal, and kinematic
variables during overground walking, at baseline and after each phase.
Status | Completed |
Enrollment | 9 |
Est. completion date | December 2008 |
Est. primary completion date | December 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 51 Years to 81 Years |
Eligibility |
Inclusion Criteria: - Idiopathic PD (previously diagnosed by one specialist physician,) - Hoehn and Yahr (H-Y) stages 2 through 3, - Absence of dementia (Mini-Mental Status Examination - MMSE, defined according to educational level) and, - Capacity to ambulate independently for at least 10 meters. Exclusion Criteria: - Change medication (dopaminergic) during the study period, - Use treadmill for at least six months prior to the study, and - Other neurologic problems or musculoskeletal, cardiovascular and respiratory disease or uncorrected visual deficit that could represent risk and interfere in the performance of the training. |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Universidade Federal de São Carlos | São Carlos | SP |
Lead Sponsor | Collaborator |
---|---|
Universidade Federal de Sao Carlos |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Significant increase in propulsive forces, stride length, speed, maximum hip extension during stance were observed after the training program. | 4 times, once before treatment, and 3 after each treatment phase. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01736891 -
Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
|
Phase 3 | |
Recruiting |
NCT03866603 -
Rostock International Parkinson's Disease Study (ROPAD)
|
||
Completed |
NCT00902941 -
Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline
|
Phase 4 | |
Completed |
NCT03103919 -
Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management
|
Phase 4 | |
Recruiting |
NCT01650610 -
Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study Protocol
|
N/A | |
Recruiting |
NCT01650623 -
Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial
|
N/A | |
Recruiting |
NCT02578849 -
Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia
|
N/A | |
Completed |
NCT01038310 -
Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
|
||
Completed |
NCT01003535 -
Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods
|
Phase 1 | |
Terminated |
NCT00562198 -
PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
|
Phase 2 | |
Completed |
NCT01580787 -
Functional Improvement in Patients With Parkinson's Disease After Training in Real or Virtual Environment
|
N/A | |
Completed |
NCT01960985 -
Balance Training in Parkinson's Disease Using Cues
|
Phase 3 | |
Completed |
NCT01391741 -
The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD)
|
Phase 3 |